Funds and ETFs Alibaba Health Information Technology Limited

Equities

241

BMG0171K1018

Drug Retailers

Delayed Hong Kong S.E. 22:45:11 2024-05-28 EDT 5-day change 1st Jan Change
3.43 HKD +1.48% Intraday chart for Alibaba Health Information Technology Limited +8.86% -18.87%

ETFs positioned on Alibaba Health Information Technology Limited

Name Weight AuM 1st Jan change Investor Rating
2.59% 293 M€ +12.56% -
1.56% 11 M€ +11.90% -
1.56% 88 M€ +14.28% -
1.42% 0 M€ 0.00% -
0.71% 14 M€ -4.84%
0.69% 2 M€ +0.14%
0.42% 122 M€ +14.05%
0.22% 10 M€ +13.36% -
0.16% 4 M€ -11.56%
0.15% 3 M€ +3.15% -
0.13% 115 M€ +4.59% -
0.11% 2 M€ +24.97%
0.04% 112 M€ +4.44% -
0.04% 4 M€ -4.41% -
0.04% 2,867 M€ +9.49% -
0.04% 153 M€ +7.49% -
0.04% 454 M€ +7.41% -
0.04% 7 M€ -.--% -
0.02% 32 M€ +7.39% -
0.01% 45 M€ 0.00% -
0.01% 34 M€ +4.49% -
0.00% 391 M€ +8.93% -
0.00% 7 M€ +5.94% -
0.00% 34 M€ +9.10% -
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities: - direct sale of pharmaceuticals (85.2%); - online sale of pharmaceuticals(12.7%); - direct healthcare services (1.8%); - online healthcare services and monitoring of pharmaceuticals (0.3%). The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%). The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.135 CNY
Average target price
5.124 CNY
Spread / Average Target
+63.41%
Consensus
  1. Stock Market
  2. Equities
  3. 241 Stock
  4. Funds and ETFs Alibaba Health Information Technology Limited